1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > CNS Drug News 04 APRIL 2016

CNS Drug News 04 APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Enhancing Portfolios Crucial To Counter Slowing CNS Development
Industry Brief - Orchid Gains Rasagiline Approval
Industry Brief - LCT Starts Phase IIb Clinical Trial Of NTCELL For Parkinson's Disease
Industry Brief - FDA Issues Complete Response Letter For Xadago
Industry Brief - First Patient Enrolled In AP-CDLD Phase III Advanced PD Trial
Industry Brief - Cynapsus/MonoSol Enter Global IP Licensing Deal
Industry Trend Analysis - Precision Medicine Reignites Alzheon's Tramiprosate Development
Industry Brief - Lupin Launches Donepezil Tablets
Industry Brief - FDA Grants Fast Track Designation To MediciNova's MN-166 For Progressive MS
Industry Brief - Eisai Withdraws NDA For Mecobalamin Treatment Of ALS
Industry Brief - Brilinta/Brilique SOCRATES Trial Misses Primary Endpoint
Industry Brief - FDA Ruling Favours Efficacy Of Fabre-Kramer's Travivo To Treat MDD
Industry Brief - FDA Issues CRL For Brintellix sNDA
Industry Brief - Rising Launches Lithium Carbonate And Metronidazole Tablets
Industry Brief - Allergan's Vraylar Now Available In US To Treat Bipolar Mania/Schizophrenia
Industry Brief - Encenicline Phase III Trials Fail To Meet Co-Primary Endpoints In CSI
Industry Trend Analysis - ADHD Revenues Will Underpin Shire's Rare Disease Pivot
Industry Brief - CHMP Recommends Marketing Of Trevicta To Treat Schizophrenia
Industry Trend Analysis - Lack Of Differentiation Will Slow Cariprazine Uptake
Industry Brief - FDA Grants Priority Review For Elite's SequestOx NDA In Pain Management
Industry Trend Analysis - Increasingly Negative Opioid Opinion Will Drive Down Consumption
Industry Brief - Glenmark Gains Frovatriptan Approval And Lacosamide Tentative Approval
Industry Brief - Cymbalta Approved For Additional Indication Of Chronic Lower Back Pain In Japan
Industry Trend Analysis - FDA's Opioid Policies Will Drive The Market Towards Alternatives
Industry Brief - Alder Reports Positive Top-Line Data From ALD403 Phase IIb Chronic Migraine Trial
Industry Brief - Remoxy NDA Resubmitted To FDA For Treating Severe Pain
Industry Brief - Alternative Analgesic Drug Demand Drives Novel Development
Industry Brief - Daiichi Sankyo Seeks Japanese Approval For Hydromorphone Hydrochloride
Industry Brief - Janssen Terminates Fulranumab Phase III Development In Osteoarthritis Pain
Industry Brief - Mylan Launches Tramadol ER Tablets
Industry Brief - ANI Receives Oxycodone Approval
Industry Brief - Methadone Oral Solution Re-Launched In Scandinavia
Industry Brief - Teva Launches Acamprosate In US
Industry Trend Analysis - Strong US Cannabinoid Approval Prospects Bolster Confidence In Class
Industry Brief - Breckenridge Gains Gabapentin Approval
Industry Brief - Fycompa Approved In Japan As Adjunctive Therapy For Partial-Onset/PGTC Seizures
Industry Brief - Ajanta Launches Levetiracetam In US
Industry Brief - Valeant To Market Mysimba In Central/Eastern Europe
Industry Trend Analysis - Return of Contrave Rights Opens Up Considerable Risk For Orexigen
Industry Brief - Tesaro Files Rolapitant IV NDA In US
Industry Brief - Ono Gains Approval For Partial Change In Proemend Labelling
Industry Brief - Second Baremsis Phase III Study Initiated In PONV
Industry Brief - Helsinn/Eisai Amend CINV Collaboration Franchise In US
Industry Trend Analysis - Disease Interception Represents Paradigm Shift For Healthcare
Industry Brief - Array/Asahi Kasei To Co-Develop TrkA Inhibitors For Novel Pain/Inflammation

Table Of Contents

CNS Drug News 04 APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

Global Radiofrequency Ablation Devices for Pain Management Market: Scope and Methodology This report on radiofrequency ablation devices for pain management market studies the current as well as future ...

Cold Pain Therapy Market by Product, Application - Forecast to 2021

Cold Pain Therapy Market by Product, Application - Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global cold pain therapy market is estimated to grow at a CAGR of 5.0% from 2016 to 2021 to reach USD 1,087.7 million by 2021. The adoption of cold pain therapy products is rising across the globe ...

Pain Management Drugs and Devices - Global Market Outlook (2016-2022)

Pain Management Drugs and Devices - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Pain Management Drugs and Devices market is expected to grow from $39.48 billion in 2015 to reach $58.2 billion by 2022 with a CAGR of 5.7%. Growing various pain ...

Analgesics In Thailand

October 2016 $ 912

Download Unlimited Documents from Trusted Public Sources

Analgesic Market in the Netherlands

  • January 2017
    14 pages
  • Analgesic  

  • Netherlands  

View report >

Anti Rheumatic and Analgesic Market in Denmark

  • January 2017
    8 pages
  • Anti Rheumatic  


  • Denmark  


View report >

Opioid Market in the US

  • January 2017
    6 pages
  • Opioid  


  • United States  

View report >

Related Market Segments :



Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.